Now, by linking these platforms, images acquired using Caption AI can be analyzed through Ultromics' EchoGo® platform, making advanced diagnostic capabilities that had been limited to experts in specialty care settings and expanding their access to more doctors and patients in more places. Ultromics' EchoGo® has dramatically eased the burden on experts by delivering automated analysis of left ventricular volumes, ejection fraction, cardiac strain, and diagnostic support of heart failure and coronary artery disease, saving significant time for users and – most importantly – improving outcomes by reducing variability between operators and equipment. Caption Guidance™, which received Breakthrough Device Designation from the FDA, is the leading AI acquisition and guidance software for cardiac ultrasound. The platforms have already begun changing this landscape. Meanwhile in the UK, the National Health Service announced it is receiving £5.9 billion to clear treatment backlogs and improve diagnostic services, reflecting the great need exacerbated by recent global events. ![]() According to a recent study, 46% of patients in the US diagnosed with heart failure in acute care settings had potential symptoms at primary care clinic visits in the previous six months – these issues were also more prevalent among women and Black patients. A limited number of specialists are available to perform and analyze cardiac ultrasounds – a key diagnostic procedure for identifying the beginning or progression of heart failure, valve disease, and coronary artery disease. ![]() ![]() Together, the companies will jointly offer the Caption AI™ software platform alongside Ultromics' EchoGo® deep ultrasound analytics – allowing a broader set of providers the ability to perform ultrasounds and automatically calculate key indicators of heart function, which drive earlier and more accurate disease diagnosis.Īccess to proper cardiac health care is a global problem, leading to countless preventable deaths. 9, 2021 /PRNewswire/ - Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced a strategic partnership to accelerate cardiovascular disease detection and treatment for more patients in more accessible care settings. BRISBANE, Calif., OXFORD, England and GUILFORD, Conn., Nov.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |